# miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction

> **NCT05632055** · — · ACTIVE_NOT_RECRUITING · sponsor: **Chiang Mai University** · enrollment: 160 (actual)

## Conditions studied

- Gestational Diabetes

## Interventions

- **OTHER:** blood draw

## Key facts

- **NCT ID:** NCT05632055
- **Lead sponsor:** Chiang Mai University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2000-08-26
- **Primary completion:** 2022-11-21
- **Final completion:** 2026-03-17
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05632055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05632055, "miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05632055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*